Logo
x

Search

Subscribe Now

Alzheimer

AbbVie Receives $20M Milestone in its DUB Targets Collaboration with Mission to Treat Alzheimer and Parkinson Diseases

AbbVie Receives $20M Milestone in its DUB Targets Collaboration with Mission to Treat Alzheimer and Parkinson Diseases

  • August 10, 2021
Prothena Presents Preclinical Data of its Alzheimer's Candidates at AAIC 2021

Prothena Presents Preclinical Data of its Alzheimer's Candidates at AAIC 2021

  • July 27, 2021
reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

  • December 4, 2020
Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence in Greater China

Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence in Greater China

  • March 18, 2020
Eisai And Biogen to Terminate Two P-III Clinical Studies of Elenbecestat (E2609) for Early Alzheimer's Disease

Eisai And Biogen to Terminate Two P-III Clinical Studies of Elenbecestat (E2609) for Early Alzheimer's Disease

  • September 13, 2019
Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer's Study

Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer's Study

  • August 9, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.